Literature DB >> 21454467

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

Nicolas Boissel, Olivier Nibourel, Aline Renneville, Pascal Huchette, Hervé Dombret, Claude Preudhomme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21454467     DOI： 10.1182/blood-2010-11-320937

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  13 in total

Review 1.  Molecular markers in acute myeloid leukaemia.

Authors:  Andrea Kühnl; David Grimwade
Journal:  Int J Hematol       Date:  2012-07-13       Impact factor: 2.490

2.  Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.

Authors:  Aline Renneville; Raouf Ben Abdelali; Sylvie Chevret; Olivier Nibourel; Meyling Cheok; Cécile Pautas; Rémy Duléry; Thomas Boyer; Jean-Michel Cayuela; Sandrine Hayette; Emmanuel Raffoux; Hassan Farhat; Nicolas Boissel; Christine Terre; Hervé Dombret; Sylvie Castaigne; Claude Preudhomme
Journal:  Oncotarget       Date:  2014-02-28

3.  Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia.

Authors:  Hsiao-Wen Kao; Der-Cherng Liang; Jin-Hou Wu; Ming-Chung Kuo; Po-Nan Wang; Chao-Ping Yang; Yu-Shu Shih; Tung-Huei Lin; Yu-Hui Huang; Lee-Yung Shih
Journal:  Neoplasia       Date:  2014-07-10       Impact factor: 5.715

Review 4.  Isocitrate dehydrogenase mutations in myeloid malignancies.

Authors:  B C Medeiros; A T Fathi; C D DiNardo; D A Pollyea; S M Chan; R Swords
Journal:  Leukemia       Date:  2016-10-10       Impact factor: 11.528

5.  Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China.

Authors:  Zhiqiang Wang; Zhibo Zhang; Yong Li; Li Sun; Dezhen Peng; Danyu Du; Xian Zhang; Luwei Han; Liwen Zhao; Ligong Lu; Hongzhi Du; Shengtao Yuan; Meixiao Zhan
Journal:  Acta Pharm Sin B       Date:  2021-03-09       Impact factor: 11.413

Review 6.  Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.

Authors:  David Grimwade; Adam Ivey; Brian J P Huntly
Journal:  Blood       Date:  2015-12-10       Impact factor: 25.476

7.  The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.

Authors:  Patrick S Ward; Chao Lu; Justin R Cross; Omar Abdel-Wahab; Ross L Levine; Gary K Schwartz; Craig B Thompson
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.486

8.  Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.

Authors:  Thomas Cluzeau; Alix Dubois; Arnaud Jacquel; Frederic Luciano; Aline Renneville; Claude Preudhomme; Jean Michel Karsenti; Nicolas Mounier; Pierre Rohrlich; Sophie Raynaud; Bernard Mari; Guillaume Robert; Patrick Auberger
Journal:  Oncotarget       Date:  2014-06-30

Review 9.  IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.

Authors:  Johanna Mondesir; Christophe Willekens; Mehdi Touat; Stéphane de Botton
Journal:  J Blood Med       Date:  2016-09-02

10.  Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

Authors:  Yann Ferret; Nicolas Boissel; Nathalie Helevaut; Jordan Madic; Olivier Nibourel; Alice Marceau-Renaut; Maxime Bucci; Sandrine Geffroy; Karine Celli-Lebras; Sylvie Castaigne; Xavier Thomas; Christine Terré; Hervé Dombret; Claude Preudhomme; Aline Renneville
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 11.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.